Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03007394 · ClinicalTrials.gov registry record · Phase 2
Lorcaserin in the Treatment of Cocaine Use Disorder
A Phase 2 study, sponsored by National Institute on Drug Abuse (NIDA).
- Completed
- Registry status
- Phase 2
- Development phase
- 272
- Enrollment target
NCT03007394 is a Phase 2 study that has completed, run by National Institute on Drug Abuse (NIDA). The registered enrollment target is 272 participants.
The verdict
NCT03007394, a Phase 2 study, has completed, sponsored by National Institute on Drug Abuse (NIDA).
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 272 participants
- Enrollment target
Study Summary
The objective of this study is to evaluate the efficacy and safety of lorcaserin in the treatment of cocaine use disorder.
Interventions
- DRUG Placebo Oral Capsule
- DRUG Lorcaserin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 272 participants |
| Start Date | 2017-12-19 |
| Est. Completion | 2019-12-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03007394
The ClinicalTrials.gov registry entry for NCT03007394 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 272 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute on Drug Abuse (NIDA), which has 335 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo Oral Capsule is the first listed.
NCT03007394 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03007394 about?
NCT03007394 is a clinical study titled "Lorcaserin in the Treatment of Cocaine Use Disorder". The objective of this study is to evaluate the efficacy and safety of lorcaserin in the treatment of cocaine use disorder.
What is the current status of trial NCT03007394?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 272 participants. The study started on 2017-12-19. Estimated completion is 2019-12-01.
What interventions are being tested in trial NCT03007394?
The interventions under investigation include: Placebo Oral Capsule (DRUG), Lorcaserin (DRUG).
Who is sponsoring clinical trial NCT03007394?
This trial is sponsored by National Institute on Drug Abuse (NIDA), which has 335 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.